In a recent episode of the Clinician's in Leadership podcast series, Arturo LoAIza-Bonilla MD shared profound insights on the role of physician leaders in healthcare innovation, the barriers they face, and how to drive meaningful change. Dr. LoAIza-Bonilla, a practicing medical oncologist, serves as the Assistant Chief of Hematology and Oncology at St. Luke's University Health Network, is a associate professor in academic medicine and clinical faculty at Temple University - Lewis Katz School of Medicine, and is the co-founder and Chief Medical Officer of Massive Bio, a technology company focusing on AI in healthcare.
Dr. LoAIza-Bonilla believes physician executives must actively shape the future of healthcare through physician leadership. He emphasized that clinicians in healthcare innovation often remain confined within their roles, focusing solely on patient care without engaging in broader decision-making processes. This, he argues, is a missed opportunity for meaningful impact. "If you're not at the table, you're on the menu," he said, underlining the importance of clinician engagement in administrative and technological advancements.
He highlighted that while physician leaders are often risk-averse due to their patient-centered approach, they must also embrace innovative solutions and take part in shaping policies and workflows that directly affect their practice. "We are the end users of healthcare technologies. We should be part of the equation as leaders, enthusiasts, and collaborators," he stated, emphasizing the importance of problem-driven research in healthcare innovation.
When asked about barriers preventing clinician innovators from leading innovation, Dr. LoAIza-Bonilla identified a significant factor: the risk-averse nature of healthcare professionals. He noted that while safety and patient outcomes are paramount, a reluctance to embrace new technologies or methods can hinder progress in solving unmet needs and finding problems worth solving.
He also emphasized the need for physician leaders to learn from both successes and failures in healthcare systems, including private practice experiences. "If I don't know what's happening elsewhere, I can't learn from others' mistakes and risk repeating them," he explained. He advocates for cross-pollination of ideas from private industries and other health systems to optimize workflows and accelerate change through collaborative leadership and multidisciplinary clinics.
Dr. LoAIza-Bonilla stressed that healthcare leaders must create environments where clinician innovators feel empowered to drive innovation. He cited the importance of swift, purposeful decision-making, similar to Amazon's "two-pizza rule" for team size, ensuring that teams remain agile and solutions-focused in the healthcare ecosystem.
He also emphasized focusing on solving critical bottlenecks in healthcare delivery before tackling broader systemic issues. "Untie the knots you can untie first," he advised, highlighting that quick wins can build credibility and momentum for larger innovations and quality improvement initiatives. This approach to leadership in empowering clinicians can significantly impact the collaborative process in healthcare innovation.
As the co-founder of MassiveBio, Dr. LoAIza-Bonilla has been at the forefront of using AI to revolutionize cancer care. Founded in 2015, MassiveBio leverages AI to match cancer patients with clinical trials, addressing critical gaps in access to cutting-edge treatments and unmet medical needs.
He stressed that building trust in AI starts with solving real-world problems that clinician innovators and patients face. "We focus on patient needs and outcomes first," he said. He warned against adopting technology for technology's sake and emphasized that AI should be a tool to enhance, not replace, clinical judgment in patient care improvement. This approach aligns with the principles of clinician-led research and problem-based innovation.
A key concern for Dr. LoAIza-Bonilla is ensuring that technological advancements reduce rather than widen health disparities. He discussed the importance of addressing social determinants of health and the digital divide, which can exclude rural and underserved populations from technological advancements and innovative solutions.
He also highlighted the need for decentralized healthcare solutions, such as telehealth and remote clinical trials, to bring services to patients rather than expecting patients to travel long distances. "We can learn from industries like Amazon and Uber, which have optimized logistics to reach customers where they are," he said, emphasizing the potential for transforming challenges into opportunities.
Discussing the slow pace of healthcare regulation compared to rapid technological advancements, Dr. LoAIza-Bonilla advocated for early collaboration with regulators and payers. He recommended a "freemium" approach, where healthcare systems can trial innovations with minimal investment before scaling successful solutions along the innovation pathway.
He also highlighted the role of government initiatives, such as ARPA-H, in fostering innovation and breaking down barriers between public and private sectors, ultimately contributing to more resilient healthcare systems and supporting the clinician-scientist workforce.
When asked how physician executives can stay ahead in a constantly evolving field, Dr. LoAIza-Bonilla emphasized the importance of continuous learning tailored to one's personal style. He shared his own habits of listening to audiobooks and podcasts during commutes and staying updated with industry trends through professional societies and Google alerts.
"Find your best learning mode and be consistent," he advised. He also stressed the importance of networking with peers, participating in professional organizations like ASCO, and engaging in local and national policy discussions to stay informed and contribute to shaping the future of healthcare through multidisciplinary healthcare leadership.
Dr. LoAIza-Bonilla concluded the conversation with a powerful reminder of the collective nature of progress in healthcare. "We are all humans, and while health systems may compete, we as individuals should collaborate. Our shared mission is to improve care for patients and make healthcare better for everyone."
His insights underscore the importance of breaking down silos, fostering a culture of innovation, and ensuring that clinician innovators play a leading role in shaping the future of healthcare. Through collaborative leadership, cross-sector collaboration, and the responsible use of technology, the future of medicine can be one that truly serves patients, clinician innovators, and communities alike, while addressing unmet medical needs and driving patient care improvement in resilient healthcare systems. By empowering clinicians and supporting problem-driven research, we can create a healthcare ecosystem that is both innovative and patient-centered.
